The number and the positions of amino functions in the aminoglycoside antibiotics are the most important parameters accounting for their powerful antibiotic activity1,2).
In the deoxystreptamine group of these drugs, the relative importance of the amino functions has been evaluated and classified as follows: 3-amino> 6'-amino> 2'-amino in terms of their relative activities on protein synthesis'). The relative importance of amino groups has also been evaluated from MIC values).
These amino moieties are also involved in the resistance of microorganisms to the drugs, since they are modified by N-acetylation catalyzed by plasmid mediated enzymes. They are also involved in drug transport mechanisms which are closely related to ribosomal binding5).
In this work, we have compared the activities of some N-substituted derivatives of tobramycin on sensitive and resistant strains. The initial assumption was that if the substitution of one amino group protects this site against further acetylation and if the resistance of strains harboring AAC enzymes is due solely to this acetylation, then this N-substituted tobramycin should have the same activity against the resistant strain as against the sensitive one. We should keep in mind that this comparison is strictly valid only if the sensitive strains are isogenic with their resistant counterparts.
In order to discuss our results in terms of resistance mechanisms, we have measured the ability of these compounds to be substrates of some aminoglycoside modifying enzymes.
Materials and Methods
Tobramycin Acetylated Derivatives 2'-N-Acetyltobramycin (2'-N-AcTo), 6'-N-acetyltobramycin (6'-N-AcTo), 3-N-acetyltobramycin (3-N-AcTo) were enzymatically synthesized, 2',6'-N,N'-diacetyltobramycin (2',6'-N,N'-diAcTo) was chemically synthesized as previously described6).
Tobramycin Ethylated Derivatives All the N-ethylated derivatives were obtained by reduction of the acetylated corresponding molecule VOL. XXXV NO. 5 THE JOURNAL OF ANTIBIOTICS by diborane. The general procedure used was as follows: the N-acetylated derivative (20~100 mg) was neutralized by 50 mm CF3COOH. The solution thus obtained was evaporated to dryness under vacuum, and the residue dissolved in 30 ml of a ]. M solution of diborane in THF. It was then refluxed for 12 hours. Then, 5 nil of water was added s..owly, the pH of the solution was brought to 10.5 and the solution was evaporated to dryness under vacuum. The residue was then dissolved in 5 ml of water and applied to a CG-50 cation exchange column (NH,+ form, 100 -200 mesh, 30 x 2 cm). Elution was performed with a gradient of ammonia from 0.1 to 1 M. The purity of the derivatives obtained was checked by TLC on silica gel plates (MeOH . 
Bacterial Strains
The MRE600 E. co/i came from the Microbial Research Establishment (England). The other bacterial isolates had been collected over the past 7 years.
Susceptibility Tests An inoculum of 105 colony forming units was used. Minimal inhibitory concentrations (MICs) were determined by two fold dilution of the antibiotics on MUELLER-HINTON agar (Baltimore Biological Laboratory, BBL) by using a multiple inoculating device (multipoint inoculator-Denley Tech., England).
In Vitro Poly U Directed Polyphenylalanine Biosynthesis The effect of tobramycin derivatives on polyphenylalanine biosynthesis was carried out as described previously".
Factors contained in an S150 ultracentrifugation fraction8) and 70 S "tight" ribosomes were prepared as described earlier9).
Misreading Induction Evaluation in Polyphenylalanine Biosynthesis
Polyphenylalanine synthesis was carried out with unlabelled phenylalanine in the presence of 10 Id of 0.5 mm (14C) L-leucine (specific activity 12.5 Ci/mole).
Modification of Tobramycin Derivatives by Aminoglycoside Modifying Enzymes
The enzymes used in the assays have been isolated as described earlier10) from appropriate strains. The assays were carried out by measuring initial rates at pH values varying from 5.5 to 8.5. The amount of modified aminoglycoside antibiotic was determined by the phosphocellulose paper binding assay2) using appropriate radiolabelled cofactors. Table 2 .
Drug concentrations necessary to induce maximum misreading of poly U (CM) are also listed.
This Table shows that N-substitution produces parallel effects at ribosomal and intact cell levels. than against strains which do not possess this enzyme. 
Inactivation of Tobramycin Derivatives with Aminoglycoside Modifying Enzymes

Discussion
The aim of the present study was to evaluate the effect of N-substitution on the biological properties of tobramycin and to discuss the results thus gathered in terms of resistance phenomena. In this respect, we have assayed two types of N-substituted derivatives: those where the substituent is an electron withdrawing group (acetyl residue) and those where the substituent does not modify the nucleophilic character of the molecule, but introduces a steric hindrance on the nitrogen atom (ethyl residue).
From Table 1 , it can be seen that, in terms of antibiotic activity, the decreasing importance of amino groups which was previously suggested3), 3-N> 6'-N> 2'-N, is valid from an electronic as well as a steric point of view. It is also obvious that the electronic effect produced by a substituent is much more important than its steric hindrance, since the N-ethyl derivatives are 16 to 32 times more active than the corresponding N-acetyl derivatives, and the ethyl monosubstitution induces only 2 to 16 fold decrease of activity.
The activities of the tobramycin derivatives (expressed in Table 2 ) on ribosomal function as inhibition of polyphenylalanine biosynthesis and induction of poly U misreading follow the same order as that observed on their MICs.
All these results are consistent with those previously described about the effects of N-acetylation on the activity of gentamicin on bacterial ribosomes3) and the effects of N-ethylation on the antibiotic activity of kanamycin A and B4 .
The expected behavior of the tobramycin derivatives against sensitive strains and on E. coli ribosomes allowed us to assay these derivatives against resistant strains with the assumption described in the introduction. It was expected that the 2'-N-ethyl derivative should have about the same activity on sensitive Proteus inconstans and on resistant Proteus inconstans PV164 harboring an AAC (2'). 6'-N Derivatives would have about the same activities on sensitive E. coil and on resistant E. coil R5 harboring an AAC (6'). 3-N Derivatives would have about the same activities on sensitive E. coli and Serratia and on E. coli R178 and Serratia 22522 respectively harboring an AAC (3). Table 3 shows that this assumption is fully verified for 2'-N-ethyl and 6'-N-derivatives, but not for 3-N derivatives. Now, let us compare these results with those described in Table 4 : 6'-N derivatives are not acetylated "in vitro" by AAC (6') I and their MICs against resistant E. coil R5 and against sensitive E. coli are identical. These results strongly suggest that the resistance of E. co/i R5 is essentially due to the presence and the activity of AAC(6') toward tobramycin. 2'-N-Ethyl derivative is a poor substrate of AAC(2'), though its MICs against resistant Proteus inconstans PV164 and against sensitive Proteus inconstans are identical. A possible explanation of this discrepancy given previously by many workers) is that the rate of drug transport is higher than its rate of enzymatic modification. Here also our results suggest that the resistance of Proteus inconstans PV164 is essentially due to the presence and the activity of AAC(2') toward tobramycin. Conversely, our assumption is not verified for the 3-N derivatives, since Table 3 shows that the MICs of 3-N-ethyltobramycin which are 8 and 32 against sensitive E. coli and Serratia rnarcescens respectively (Table 1) , increase to 128 and 2048 against E. coil R116 and Serratia inarcescens 22522 harboring an AAC(3) ( Table 3 ). The same phenomenon can be pointed out for 3-N-acetyltobramycin.
However, Table 4 clearly indicates that 3-N derivatives are not substrates for AAC (3) . These results suggest strongly that the presence and the activity of AAC(3) in E. coli R11 and Serratia marcescens 22522 are not sufficient to explain the resistance of these bacteria to tobramycin. As previously reported11,12), it is likely that the presence of the R plasmid coding for AAC(3), in E. coli R176 and in Serratia marcescens 22522 affects directly the cell envelope and as a consequence modifies drug transport. The comparison of other results can be explained if we consider the presence and the activity of modifying enzymes, the drug transport, and also the competition between modification rate and transport rate of the drug5,13).
Moreover, 3-N-ethyltobramycin has a singular behavior: it is modified by ANT(4') and AAC(6') less than 2'-N-ethyltobramycin and tobramycin; yet, I values are never weaker towards the former compound. These results suggest that 3-N-ethyltobramycin is more sensitive than 2'-N-ethyltobramycin and tobramycin to modification of drug transport.
If we now consider the effect of N-substitution on the efficiency of aminoglycoside modifying enzymes, it can be seen that 6'-N-and 3-N positions are more important than 2'-N position since 2'-N-ethyltobramycin is a substrate of almost all enzymes and 2'-N-acetyltobramycin a substrate of AAC(6')I, ANT (2") and AAC(3)IV. 6'-N-Acetyltobramycin, 3-N-acetyltobramycin and 3-N-ethyltobramycin are only modified by ANT (2") and 6'-N-ethyltobramycin is a substrate of AAC(2') and ANT(4').
It is noteworthy that ANT(2") is little or not influenced by monosubstitution at 3-N, 6'-N and 2'-N positions, since even the acetylated derivatives are substrates; and also that 2',6'-NN'-diethyltobramycin is the only derivative to retain a fairly good antibiotic activity on E. coil R55.
In conclusion, the present work provides some additional arguments that 3-N>6'-N-2'-N is the decreasing order of importance of the amino groups of aminoglycosides in the expression of antibiotic activity, effectiveness at ribosomal level, and susceptibility of the drug to be transformed by plasmid mediated modifying enzymes. It also provides additional arguments that in some cases, the presence and activity of modifying enzyme is sufficient to explain strain resistance, but that in other cases we must put forward a modification of drug transport which makes it particularly sensitive to modifications on the 3-N position.
